MedX Health Corp

Equities

MDX

CA5850901037

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. Other stock markets 14:37:29 12/07/2024 BST			5-day change	1st Jan Change
0.07 ^CAD	0.00%		0.00%	+16.67%

05-31	MedX Health Corp. Brief: Announced Proposed Extension of Non-brokered Private Placement Offering	MT
05-30	MedX Health Corp Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Medx Health Corp. Announces Skin Cancer Pilot Program in Collaboration with Calian Primacy Clinics

January 09, 2017 at 11:39 pm

MedX Health Corp. announced that, it has entered into a memorandum of understanding with Calian Health's Primacy Management Inc., to conduct a pilot program with MedX's unique skin assessment screening solution in select Primacy clinics.

Latest news about MedX Health Corp

MedX Health Corp. Brief: Announced Proposed Extension of Non-brokered Private Placement Offering	05-31	MT
MedX Health Corp Reports Earnings Results for the First Quarter Ended March 31, 2024	05-30	CI
MedX Health Corp announced that it expects to receive CAD 2 million in funding	04-30	CI
MedX Health Corp Reports Earnings Results for the Full Year Ended December 31, 2023	04-30	CI
MedX Health Corp. and Health Partners Group Limited Announce Successful Results of its Pilot Project in the United Kingdom and Move Towards A Partnership Agreement	02-28	CI
MedX Health Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-28	CI
MedX Health Corp announced that it has received CAD 1.02 million in funding	11-13	CI
MedX Health Corp. Announcing Proposed Extension of Non-Brokered Private Placement Offering	12/10/23	MT
MedX Health Corp announced that it expects to receive CAD 1.5 million in funding	29/08/23	CI
MedX Health Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23	CI
MedX Health Corp Reports Earnings Results for the First Quarter Ended March 31, 2023	29/05/23	CI
MedX Health Corp. Brief: Appointing Stephen Lockyer as CEO	10/05/23	MT
MedX Health Corp Announces Resignation of Naman Damaghlatrous as Director	10/05/23	CI
MedX Health Corp. Announces Chief Executive Officer Changes	10/05/23	CI
MedX Health Corp Reports Earnings Results for the Full Year Ended December 31, 2022	02/05/23	CI
MedX Health Corp Auditor Raises 'Going Concern' Doubt	30/04/23	CI
MedX Health Details Board Changes	25/04/23	MT
MedX Health Corp Announces Board Changes	25/04/23	CI
MedX Health, PharmaChoice Enter MOU to Launch MedX Teledermatology Screening Platform Across Canada	18/04/23	MT
MedX Health Corp and Pharmachoice Announces Agreement to Launch Medx Teledermatology Screening Platform Across Canada	18/04/23	CI
MedX Health Corp announced that it has received CAD 1.465 million in funding from Forest Lane Holdings Limited	16/03/23	CI
MedX Health Plans to Undertake $1.5 Million Convertible Debenture Financing	30/01/23	MT
MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited	29/01/23	CI
MedX Health Corp announced that it has received CAD 1.5 million in funding from Forest Lane Holdings Limited	05/01/23	CI
MedX Health Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	28/11/22	CI

Chart MedX Health Corp

Duration

Period

More charts

Company Profile

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.

Sector

Advanced Medical Equipment & Technology

Calendar

26/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
MEDX HEALTH CORP	+16.67%	13.78M
THERMO FISHER SCIENTIFIC	+4.64%	212B
DANAHER CORPORATION	+8.99%	187B
INTUITIVE SURGICAL, INC.	+29.83%	155B
BOSTON SCIENTIFIC CORPORATION	+35.17%	115B
SIEMENS HEALTHINEERS AG	+1.67%	65.5B
EDWARDS LIFESCIENCES CORPORATION	+15.06%	52.87B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.47%	45.25B
AGILENT TECHNOLOGIES, INC.	-2.14%	39.7B
GE HEALTHCARE TECHNOLOGIES INC.	+6.88%	37.72B

Other Advanced Medical Equipment & Technology